Interleukin‑22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway

Zhiqiang Li(Jiangxi University of Traditional Chinese Medicine), Yu Xiao(Shanghai Sixth People's Hospital)
Experimental and Therapeutic Medicine
December 19, 2019
Cited by 5


Related Papers